echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Yinchuan City prescriptions all outflow, to solve the problem of licensing practicing pharmacists

    Yinchuan City prescriptions all outflow, to solve the problem of licensing practicing pharmacists

    • Last Update: 2021-03-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Yinchuan City prescription audit and transfer platform access to 6 municipal hospitals, hospital prescriptions all outflow, in addition, Yinchuan City Health and Health Commission Director Ma Xiaofei made it clear that the platform solved the problem of licensing practicing pharmacists.
    ▍ the total outflow of prescriptions, to solve the problem of licensing practicing pharmacists
    A few days ago, the National Health and Wellness Commission held a regular press conference to introduce the healthy development of the Internet and medical care and the situation related to the service for the benefit of the people. Ma Xiaofei, director of Yinchuan Health Committee of Ningxia Hui Autonomous Region, introduced the "Yinchuan City prescription review and transfer platform" many times.
    understand that this prescription review flow platform will be all hospitals, communities and Internet hospitals in the city prescriptions, unified audit, to ensure the safety of drug use. At the same time, patients can choose their own pharmacy and purchase method according to the lowest price, the closest distance, self-service drug withdrawal or third-party distribution and other options.
    To this, Yinchuan City First People's Hospital in a room less than 50 flat, sitting in front of the computer review of 15 pharmacists, Ma Xiaofei called them Yunhua pharmacists, this is Yinchuan City prescription review flow platform.
    , Yinchuan City, six municipal hospitals have all access to the drug audit and transfer platform, the hospital prescriptions all outflow. Ma Xiaofei introduced: "The common people will no longer say that the hospital by selling medicine to make money, the hospital's medicine sold expensive people can go to the pharmacy to get." In
    , Ma Xiaofei made it clear that Yinchuan City prescription review and transfer platform to solve the problem of licensing practicing pharmacists. Through the cloud of pharmacists, in-live hospital pharmacists stock, pharmacists on the Internet at any time, and through the trial of clinical pharmacists will also increase the income.
    ▍ to alleviate the shortage, the income of practicing pharmacists increased?!
    shortage of practicing pharmacists is an unquestionable fact. As of the end of November 2018, there were 489,000 pharmacies nationwide, up 35,000 from the same period last year, according to the 2018 Annual Report on Drug Regulatory Statistics in early May. At the same time, as of the end of March 2019, there were 429,000 licensed pharmacists registered with pharmaceutical retail companies.
    gap between practicing pharmacists, so that many pharmacies and practicing pharmacists have to register, even if the opening of remote adjudication, no trial is a problem.
    This prescription review flow platform, clinical pharmacists have reviewed the outflow of prescriptions, no need for practicing pharmacists to review the prescription, reducing the hard demand for practicing pharmacists, will to a certain extent alleviate the pressure of the shortage of practicing pharmacists.
    Ever, the industry media search drug analysis, this time through the trial, the income of clinical pharmacists to improve, its essence is "pharmacy service fees", the future of the platform large-scale access to pharmacies, more perfect technology, through the reform of the new compensation incentive system, the possibility of practicing pharmacists to collect "pharmacy service fees" is gradually increased.
    ▍ Priority layout of prescription outflow, will seize the advantage
    Guoyuan Securities Research Report analysis, the current prescription outflow still has three major sources of problems: prescription sources (i.e., external mobility), medical insurance co-ordination and pharmacy capacity, has not been properly resolved, the significant trend has not yet begun.
    of out-of-prescription exodlicism has been positive, but little has been achieved, and since 2015 there has been an outflow of benefits through policies such as drug separation.
    Has long been difficult for in-hospital prescriptions to become the cost side of hospitals, with prescription drugs accounting for more than 80% of sales in hospitals and retail pharmacies accounting for only 16.3%, well below the 83% in the United States and 71.7% in Japan. In the past, China implemented "pharmaceutical integration", hospitals from the drug sales plus profits, doctors' assessment indicators and drug prescriptions linked to form a certain amount of interest.
    in the past, the source of prescription exoded was difficult to solve.
    This time, Yinchuan City's prescription review and transfer platform will be the hospital prescriptions all outflow, this model has also been introduced and recommended by the National Health and Safety Commission, if the scope of the pilot is expanded, may promote the development process of prescription outflow in the future.
    same time, the continued impact of the "4 plus 7" centralized procurement, a large number of pharmaceutical sales teams began to shift the focus away from public hospitals, which invisibly gave the retail pharmacy industry more opportunities. Without considering the decline in gross margin of varieties due to future harvesting, centralized procurement of medicines will undoubtedly accelerate the process of prescription outflow. It can be seen that prescription outflow is a long-term irreversible trend, national supporting measures will keep up, enterprises need to plan ahead, long-term layout, and hospital side shops and DTP prescriptions will be the most easy to undertake the pattern of prescription outflow, early layout of the hospital side shop and DTP pharmacy leading enterprises have the advantage of priority to seize the rapid development of prescription outflow. (Yu News/Guoyuan Securities)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.